subject: Aarkstore Enterprise---cochlear Limited (coh) - Financial And Strategic Analysis Review [print this page] Cochlear Limited (Cochlear) is engaged in the development and manufacture of electronic implantable hearing devices. The companys products are suited for people with hearing loss caused by ear nerve damage. The company mainly operates in the US, Australia, and Europe. It markets and distributes its products worldwide through its subsidiaries. The company is headquartered in New South Wales, Australia. The company classifies its geographical locations into three regions, namely, Europe, the Americas, and Asia Pacific. The Europe region accounted for 44.8% of the total revenues of the company for the fiscal year ended 2009, followed by America (42.2%), and Asia Pacific (13%).
Cochlear Limited Key Recent Developments
Aug 13, 2010 Cochlear Sets Up New Subsidiary In India
Jul 11, 2010 Cochlear To Spend $15 Million Over Five Years In India
Mar 17, 2010 Cochlear Announces Retirement Of Tommie Bergman As Chairman And Non-Executive Director
Oct 14, 2009 Cochlear And NXP Collaborate To Enable Cochlears Next Generation Hearing Implant Products
Sep 04, 2009 Cochlear Introduces Three Implantable Hearing Solutions In India
This comprehensive SWOT profile of Cochlear Limited provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
